Analytical power meets comprehensive and connected data
Accelerate drug development and reduce costs by exploring in depth the complete data and information landscape around your product.
- Understand the biology of complex disease and identify better target-disease relationships
- Investigate molecular disease subtypes to identify and address responder patient populations
- Reveal new promising targets for the development of novel therapies
- Augment the value of pipeline drug candidates and portfolio drugs
- Optimize clinical trial structure, size, and relevant study cohorts
- Anticipate risks and mitigate failure of candidates at clinical stage
Where Dataome Technology creates value in drug development
Eliminate bottlenecks in drug development and create new opportunities to expand the uses of approved drugs or drug candidates. Our team works with you in identifying and qualifying targets and patient populations, predicting safety risks, prioritizing indications, and optimizing clinical trial design.
Click to enlarge
Click to enlarge
How Dataome Technology generates new knowledge
Through proprietary text-mining and integration of data from multiple global sources, Dataome Technology assimilates and structures an unparalleled body of information that is then organized into a highly interconnected knowledgebase of expert-curated quality. Those data can then be interrogated via a unique portfolio of analytical technologies and AI methods.
What makes Dataome Technology unique
Dataome intimately connects disparate data domains, extending the dimensions of analytical possibilities. Every aspect of this evidence capturing and analysis is supervised by a team of subject matter experts who understand which data and insights are essential to successfully transform drug discovery, clinical development, and patient care.
Click to enlarge
Dataome Technology facilitates evidence-based decisions
The right collaboration for success
fee for service
Leverage Dataome Technology to answer project-specific clinical and scientific questions.
co-development
Jointly develop new drugs, disease models, clinical trials, and share intellectual property via a custom licensing agreement.
adoption & co-financing
Licence or buy out targets as well as programs after careful assessment using Dataome Technology.
Still have questions?
References: [1] Nat Rev Clin Oncol. 2011; 8:735. PMID 21989071; [2] Clin Pharmacol Ther. 2021; 109:1232. PMID: 33090463; [3] Cancer Cell. 2015 Nov 9;28(5):610-22. PMID: 26481148